Trial NCT00976677

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2011-01967
Secondary IDs: CDR0000654212 E2508 ECOG-E2508 NCI-2011-01967 U10CA021115

Last trial update was posted on 2014-05-30

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Bevacizumab Carboplatin Erlotinib Hydrochloride Immunoglobulins Paclitaxel

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Recurrent Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID